RHS Financial’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$686K Buy
1,760
+77
+5% +$32.6K 0.28% 73
2026
Q1
$796K Buy
1,683
+176
+12% +$88.6K 0.38% 56
2025
Q4
$704K Buy
1,507
+534
+55% +$248K 0.34% 59
2025
Q3
$415K Buy
973
+101
+12% +$39.1K 0.22% 77
2025
Q2
$334K Sell
872
-8
-0.9% -$2.88K 0.19% 91
2025
Q1
$304K Sell
880
-25
-3% -$8.04K 0.17% 102
2024
Q4
$272K Sell
905
-79
-8% -$27.6K 0.14% 113
2024
Q3
$400K Buy
+984
New +$360K 0.2% 87

Other funds holding HCA

RHS Financial's HCA Position: Q2 2026 in Review

RHS Financial increased its HCA Healthcare (HCA) stake by 4.6% in Q2 2026, buying an estimated $32.6K and bringing the position to 1,760 shares worth $686K. The position accounts for 0.28% of the portfolio, ranked #73.

RHS Financial first reported a position in HCA in Q3 2024 and has held it in 8 quarters since. The position peaked at $796K in Q1 2026. 1,340 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • RHS Financial held 1,760 shares of HCA Healthcare worth $686K as of Q2 2026.
  • RHS Financial bought 77 HCA Healthcare shares in Q2 2026, an estimated $32.6K.
  • HCA Healthcare made up 0.28% of RHS Financial's portfolio in Q2 2026, its #73 holding.
  • RHS Financial first reported a position in HCA Healthcare in Q3 2024 and has held it in 8 quarters since.
  • RHS Financial's HCA Healthcare position peaked at $796K in Q1 2026.
  • 1,340 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on RHS Financial's 13F filing for Q2 2026, filed 7 Aug 2026.